These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32710971)

  • 1. The indirubin derivative 6-bromoindirubin-3'-glycerol-oxime ether (6BIGOE) potently modulates inflammatory cytokine and prostaglandin release from human monocytes through GSK-3 interference.
    Czapka A; König S; Pergola C; Grune C; Vougogiannopoulou K; Skaltsounis AL; Fischer D; Werz O
    Biochem Pharmacol; 2020 Oct; 180():114170. PubMed ID: 32710971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromo-substituted indirubins for inhibition of protein kinase-mediated signalling involved in inflammatory mediator release in human monocytes.
    Bachmann V; Schädel P; Westhoff J; Perić M; Schömberg F; Skaltsounis AL; Höppener S; Pantsar T; Fischer D; Vilotijević I; Werz O
    Bioorg Chem; 2024 Aug; 149():107470. PubMed ID: 38838619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery of 6-bromoindirubin-3'-glycerol-oxime ether employing poly(D,L-lactide-co-glycolide)-based nanoencapsulation techniques with sustainable solvents.
    Czapka A; Grune C; Schädel P; Bachmann V; Scheuer K; Dirauf M; Weber C; Skaltsounis AL; Jandt KD; Schubert US; Fischer D; Werz O
    J Nanobiotechnology; 2022 Jan; 20(1):5. PubMed ID: 34983538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of glioma-inflammation crosstalk profiles in human glioblastoma cells by indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3'-oxime (7BIO).
    Scobie MR; Houke HR; Rice CD
    Chem Biol Interact; 2019 Oct; 312():108816. PubMed ID: 31505164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Indirubin Derivative 6-Bromoindirubin-3'-Oxime Activates Proteostatic Modules, Reprograms Cellular Bioenergetic Pathways, and Exerts Antiaging Effects.
    Tsakiri EN; Gaboriaud-Kolar N; Iliaki KK; Tchoumtchoua J; Papanagnou ED; Chatzigeorgiou S; Tallas KD; Mikros E; Halabalaki M; Skaltsounis AL; Trougakos IP
    Antioxid Redox Signal; 2017 Nov; 27(14):1027-1047. PubMed ID: 28253732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-bromo-indirubin-3'-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts.
    Sklirou AD; Gaboriaud-Kolar N; Papassideri I; Skaltsounis AL; Trougakos IP
    Sci Rep; 2017 Sep; 7(1):11713. PubMed ID: 28916781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
    Ribas J; Bettayeb K; Ferandin Y; Knockaert M; Garrofé-Ochoa X; Totzke F; Schächtele C; Mester J; Polychronopoulos P; Magiatis P; Skaltsounis AL; Boix J; Meijer L
    Oncogene; 2006 Oct; 25(47):6304-18. PubMed ID: 16702956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein kinase 3.
    Efstathiou A; Gaboriaud-Kolar N; Smirlis D; Myrianthopoulos V; Vougogiannopoulou K; Alexandratos A; Kritsanida M; Mikros E; Soteriadou K; Skaltsounis AL
    Parasit Vectors; 2014 May; 7():234. PubMed ID: 24886176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Br-5methylindirubin-3'oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis.
    Xingi E; Smirlis D; Myrianthopoulos V; Magiatis P; Grant KM; Meijer L; Mikros E; Skaltsounis AL; Soteriadou K
    Int J Parasitol; 2009 Oct; 39(12):1289-303. PubMed ID: 19445946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of GSK-3 reduces prostaglandin E2 production by decreasing the expression levels of COX-2 and mPGES-1 in monocyte/macrophage lineage cells.
    Noma T; Takahashi-Yanaga F; Arioka M; Mori Y; Sasaguri T
    Biochem Pharmacol; 2016 Sep; 116():120-9. PubMed ID: 27453433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells.
    Zhang X; Castanotto D; Nam S; Horne D; Stein C
    Mol Ther; 2017 Jan; 25(1):79-91. PubMed ID: 28129131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirubin-3'-oxime prevents hepatic I/R damage by inhibiting GSK-3beta and mitochondrial permeability transition.
    Varela AT; Simões AM; Teodoro JS; Duarte FV; Gomes AP; Palmeira CM; Rolo AP
    Mitochondrion; 2010 Aug; 10(5):456-63. PubMed ID: 20433952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirubin core structure of glycogen synthase kinase-3 inhibitors as novel chemotype for intervention with 5-lipoxygenase.
    Pergola C; Gaboriaud-Kolar N; Jestädt N; König S; Kritsanida M; Schaible AM; Li H; Garscha U; Weinigel C; Barz D; Albring KF; Huber O; Skaltsounis AL; Werz O
    J Med Chem; 2014 May; 57(9):3715-23. PubMed ID: 24697244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirubin derivative 6BIO suppresses metastasis.
    Braig S; Kressirer CA; Liebl J; Bischoff F; Zahler S; Meijer L; Vollmar AM
    Cancer Res; 2013 Oct; 73(19):6004-12. PubMed ID: 23946383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S632A3, a new glutarimide antibiotic, suppresses lipopolysaccharide-induced pro-inflammatory responses via inhibiting the activation of glycogen synthase kinase 3β.
    Deng H; Zhang N; Wang Y; Chen J; Shen J; Wang Z; Xu R; Zhang J; Song D; Li D
    Exp Cell Res; 2012 Dec; 318(20):2592-603. PubMed ID: 22975730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations.
    Rivest P; Renaud M; Sanderson JT
    Chem Biol Interact; 2011 Feb; 189(3):177-85. PubMed ID: 21111724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirubin-3'-oxime inhibits inflammatory activation of rat brain microglia.
    Jung HJ; Nam KN; Son MS; Kang H; Hong JW; Kim JW; Lee EH
    Neurosci Lett; 2011 Jan; 487(2):139-43. PubMed ID: 20946938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirubin-3'-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling.
    Lee MJ; Kim MY; Mo JS; Ann EJ; Seo MS; Hong JA; Kim YC; Park HS
    Cancer Lett; 2008 Jul; 265(2):215-25. PubMed ID: 18343569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirubin-3-Oxime Effectively Prevents 6OHDA-Induced Neurotoxicity in PC12 Cells via Activating MEF2D Through the Inhibition of GSK3β.
    Hu S; Cui W; Zhang Z; Mak S; Xu D; Li G; Hu Y; Wang Y; Lee M; Tsim KW; Han Y
    J Mol Neurosci; 2015 Dec; 57(4):561-70. PubMed ID: 26346600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.
    Coant N; Simon-Rudler M; Gustot T; Fasseu M; Gandoura S; Ragot K; Abdel-Razek W; Thabut D; Lettéron P; Ogier-Denis E; Ouziel R; Devière J; Lizard G; Tellier Z; Lebrec D; Moreau R
    J Hepatol; 2011 Oct; 55(4):784-93. PubMed ID: 21334395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.